Posted 3/5/2020 12:24 PM (GMT -5)
Thank you, Sr Sailor. Honestly, I was surprised that my Vanderbilt surgeon (at least according to the nurse practitioner who communicates for him) was not aware of the issue with the PSA test, because he is listed as
one of the authors on the Vanderbilt study. I know the study was done in 2008-2010 (published in 2011), and he probably wasn't involved in the actual compiling of information and writing of the paper. Also, that study concluded that no patient at Vanderbilt was overtreated as a result of undetected heterophilic antibodies. However, the last sentence of the paper (not the abstract) states, "When using PSA for post-prostatectomy
surveillance, it is crucial to confirm concerning values and always consider the presence of heterophilic antibodies if the PSA value does not correlate with the clinical scenario." I am seeing another RO at Vanderbilt
tomorrow and am seeing my family doctor next week. I hope that one of them will agree to do the Post-Prostatectomy PSA with HAMA treatment and the test for Rheumatoid Factor. As I said before, I realize I'll probably have to have radiation but just want to be diligent in ruling out the possibility of PSA test interference
so that I can feel good about going ahead with radiation. I'm thinking that because this is a rare phenomenon,
the "powers that be" don't consider it cost effective to test with the Scantibodies blocking tubes used in the
study and that this rare issue isn't considered statistically significant, but it is significant to me! I feel kind of
like my wife and I are on a desert island with our feet in quick sand trying to deal with this even though I am
being treated at a highly respected medical institution! Thank you for listening to all of this and for your good
wishes! I will report back regarding any further testing and my path forward.